Showing results (1801-1810 of 3,496) with videos related to

Sort By:
Pageof 350
Archiv Der Pharmazie|September 22, 2020
1,2,3-Triazole hybrids with anti-HIV-1 activityLian-Shun Feng, Man-Jie Zheng, Feng Zhao, et al.
Archiv Der Pharmazie|October 5, 2020
Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitorsWasim Akhtar, Akranth Marella, Mohammad Mumtaz Alam, et al.
Archiv Der Pharmazie|October 8, 2020
Synthesis and antimicrobial activity of new 2-piperazin-1-yl-N-1,3-thiazol-2-ylacetamides of cyclopenta[c]pyridines and pyrano[3,4-c]pyridinesSamvel Sirakanyan, Victor Kartsev, Domenico Spinelli, et al.
Archiv Der Pharmazie|July 27, 2021
Synthesis of new 7-amino-3,4-dihydroquinolin-2(1H)-one-peptide derivatives and their carbonic anhydrase enzyme inhibition, antioxidant, and cytotoxic activitiesHasan Küçükbay, Zeynep Gönül, Fatümetüzzehra Zehra Küçükbay, et al.
Archiv Der Pharmazie|July 27, 2021
Nanomolar potency of imidazo[2,1-b]thiazole analogs as indoleamine 2,3-dioxygenase inhibitorsMenna A Ewida, Heba A Ewida, Mahmoud S Ahmed, et al.
Archiv Der Pharmazie|July 29, 2021
Leishmanicidal and cytotoxic activities and 4D-QSAR of 2-arylidene indan-1,3-dionesAna P M de Souza, Maria C A Costa, Alex R de Aguiar, et al.
Archiv Der Pharmazie|November 21, 2022
Thienopyrimidine-based agents bearing diphenylurea: Design, synthesis, and evaluation of antiproliferative and antiangiogenic activityEsmaeil Mohammadian, Tayebeh Oghabi Bakhshaiesh, Abolghasem Jouyban, et al.
Archiv Der Pharmazie|June 6, 2022
Design, synthesis, biological evaluation, and in silico studies of 2-aminobenzothiazole derivatives as potent PI3Kα inhibitorsKashif Haider, Kamal Ahmad, Abul Kalam Najmi, et al.
Archiv Der Pharmazie|June 17, 2022
The medicinal perspective of 2,4-thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A reviewKumari Kajal, Gurpreet Singh, Tathagata Pradhan, et al.
Pageof 350